Vor Biopharma OverviewVor Biopharma EBIT
EBIT (Earnings Before Interest and Taxes) analysis for VOR.
Quarterly EBIT
-$35.16M
↓ 5.61% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$375.61M
↓ 207.5% YoY
Trailing 12 months ending Mar 31, 2026
Vor Biopharma OverviewEBIT (Earnings Before Interest and Taxes) analysis for VOR.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026